Malignant progression and resistance of cancer cells: An inducible survival program similar to the SOS program of unicellular organisms induced by aggressions from the environment ?;La progression dans la malignité des cellules cancéreuses et leur résistance: Un programme inductible de survie similaire au système SOS des êtres unicellulaires, indult par les agressions environnementales ?

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 1, 1998, Pages 49-57

  Israël, Lucien ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b CNRS   (France)

Author keywords

Cell survival; Mutation; Neoplasms, genetics; Stress, genetics

Indexed keywords

CARCINOGEN;

BACTERIUM; CELL SURVIVAL; DISEASE COURSE; DNA REPAIR; DRUG EFFECT; GENETICS; NEOPLASM; PATHOLOGY; REVIEW;

BACTERIA; CARCINOGENS, ENVIRONMENTAL; CELL SURVIVAL; DISEASE PROGRESSION; NEOPLASMS; SOS RESPONSE (GENETICS);

EID: 0031604931     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. NOWELL P.C. - The clonal evolution of tumor cell populations. Science, 1976, 194, 23-28.
2. CAIRNS J. - Mutational selection and the natural history of cancer. Nature, 1975, 255, 197-200.
3. RADMAN M. - SOS repair hypothesis : phenomenology of an inducible repair which is accompanied by mutagenesis. In Hanawactp. Setlow R.B. eds. Molecular mechanisms for DNA repair. Part. A. New York : Plenum Publishing Corp., 1975, 355-367.
4. DEVORET R. - Mécanisme de la mutagénèse SOS chez les bactéries. Médecine/Sciences, 1993, 9, 1-7.
5. ISRAËL L. - Tumour progression : random mutations or an integrated survival response to cellular stress conserved from unicellular organisms ? J. Theor. Biol., 1996, 178, 375-380.
6. ISRAËL L. - The behavior of metastases from spontaneous human tumors : therapeutic possibilities and limitations. Bull. Inst. Pasteur, 1994, 92 [4], 230-234.
7. GRAHAM C.H., KOBAYASHI H., STANKIEWICZ K.S., MAN S., KAPITAIN S.J., KERBEL R.S. - Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J. of the Nat. Cancer Int., 1994, 86 [13], 975-982.
8. ISRAËL L., CHAHINIAN P. - Rates and patterns of growth of lung cancer. In : Lung Cancer, Natural History Prognosis and Therapy, 1976, New York : Academic Press.
9. PARSON R., LI G.M., LONGLEY M., MODRICH P., LIU B., BERK T., HAMILTON S.R., KINZLER K.W., VOGELSTEIN B. - Mismatch repair deficiency in phenotypically normal cells. Science, 1995, 268, 738-740.
10. DECLOS K.B., NAGLE D.S., BLUMBERG P.M. - Specific binding of phorbol ester tumor promoters to mouse skin. Cell, 1980, 19, 1025-1032.
11. PARODI S., BRAMBILLA G. - Relationships between mutation and transformation frequencies in mammalian cells treated in vitro with chemical carcinogens. Mut Res., 1977, 47, 53-74.
12. RUBIN H. - Is somatic mutation the major mechanism of malignant transformation ? J. Natl Cancer Inst., 1980, 61 [5], 995-1000.
13. CHOWO M., TAO A., RUBIN H. - Cellular epigenetics : topochronology of progressive « spontaneous » transformation of cells under growth constraints. Proc. Natl. Acad. Sci., 1994, 91, 599-603.
14. PARSHAD R., SANDFORD K. - Effect of horse serum, fetal calf serum, calf serum, bovin serum and fetuin on neoplasic conversion and chromosomes of mouse embryo cells in vitro. Natl. Cancer Inst., 1968, 41, 767-779.
15. DOBROVIC A., SIMPFENDORFER D. - Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Research, 1997, 57 [16], 3347-3350.
16. HOCKEN-BERY M.D., OLTAVAI N., YIN X.M., MILLMAN C.L., KORSMEYER J.J. - Bcl2 functions as an antioxidant pathway to prevent apoptosis. Cell, 1993, 75, 241-251.
17. KUNDU N., ZHANG J., FULTON A.M. - Sublethal oxidative stress inhibits tumor cell adhesion and enhances experimental metastases of a murine mammary carcinoma. Clin. Exp. Metast., 1995, 13, 1, 16-22.
18. OSTERREICH S., WENG C.N., KIU M., HIBENBEK J.G., OXBORNE C.K., FUQUA S.W. - The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer lines. Cancer Res., 1993, 4443-4448.
19. FULLER K.J., ISSELS O., GUILLET J.G., SOUSSI T., POLLA B.S. - Cancer and the heat shock proteins. Eur. J. Cancer, 1994, 304, 1884-1891.
20. MOMAND J., ZAMBETTI G.P., OLSON D.C., GEORGE D., LEVINE A.S. - The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell, 1992, 69, 1237-1245.
21. KHATIB Z.A., MATSUCHIME H., VALENTINE M. et al. - Co-amplification of the CD4 gene with mdm2 and GLI in human sarcomas. Cancer Res., 1993, 53, 5535-5541.
22. KIM N.W., PIATYSEK M.A., PROWSE K.R., HARLEY C.B., WEST M.D., HO P.L.C. et al. - Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266, 2011-2015.
23. TAKODA T., HAYASHI M., KOMINAMI R. - Telomer elongation frequently observed during tumor metastasis. Jpn J. cancer Res., 1992, 83, 112-127.
24. TADDEI F., MATIC I., RADMAN M. - Mutagènes et adaptation. Médecine/Sciences, 1997, 3 [13], I-VI.
25. FRIEDBERG E.C., WALKER G.C., SIEDE W. - Mismatch repair. In : DNA Repair and Mutagenesis, 1995. Washington : ASM Press.
26. LOEB L.A. - Microsatellile instability : marker of a tumor phenotype in cancer. Cancer Res., 1994, 54, 5059-5063.
27. PALOMBO F., HUGHES M., JIRICNY J., TRUONG O., HSUAN J. - Mismatch repair and cancer. Nature, 1994, 367, 417.
28. BRIDGES B.A. - Hypermutation under stress. Nature, 1997, 387, 557-558.
29. ISRAËL L. - Le phénomène cancéreux. In : Manuel de Thérapetique Médicale, Paris : Masson, 1991.
30. SEDGWICK S.G., YARRANTON G.T. - How cells in distress use SOS. Nature, 1982, 296, 606-607.
31. FRIEDBERG E.C., WALKER G., SIEDE W. - SOS responses and DNA damage tolerance in prokaryotes. In : DNA Repair and Mutagenesis, 1995. Washington : ASM Press.
32. HORII T., OGAWA T., NAKATANI T., HASE T., MATSUBARA H., OGAWA H. - Regulation of SOS functions : purification of E. coli Lex A protein and determination of its specific site cleaved by the Rec A protein. Cell, 1981, 27, 515-522.
33. MARGULIS L. - Origin of eukaryote cells, 1970, Vol. 1, Yale : University Press.
34. SCHWARTZ R.M., DAYHOFF M.O. - Origin of prokaryotes, eukaryotes, mitochondria and chloroplasts. Science, 1978, 199, 395-403.
35. LANGRIDGE J. - Molecular Genetics and Comparative Evolution. Taunton : Research Studies Press, 1991, Vol. 1.
36. FOJO A.T., VEDA K., SLAMON D.S. et al. - Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA, 1987, 84, 265-269.
37. SHINOHARA A., OGAWA H., MATSUDA Y., USHIO N., IKEO K., OGAWA T. - Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nature Genetics, 1993, 4 [3], 239-243.
38. SARASIN A. - SOS response in mammalian cells. Cancer Invest., 1985, 3, 153-174.
39. RADMAN M., TADDEI F., HALLIDAY J. - Correction des erreurs dans l'ADN : de la génétique bactérienne aux mécanismes de prédisposition héréditaire aux cancers chez l'homme. Médecine/Sciences, 1994, 10, 1024-1030.
40. HOLLIDAY R. - Understanding aging. Cambridge University Press, 1995.
41. SERVICE R. - Slow DNA repair implicated in mutations found in tumors. Science, 1994, 263, 1374.
42. CADMAN E.C - The selective transfer of resistance genes in malignant cells. In Resistance to antineoplastic agent (Kersel D ed). CRC Press, 1989, 168-183.